COVID-19 Impact on Global Myasthenia Gravis (MG) Treatment Market Size, Status and Forecast 2020-2026

September 2020 | 93 pages | ID: CE52949DBEC3EN
QYResearch

Abstracts

This report focuses on the global Myasthenia Gravis (MG) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Myasthenia Gravis (MG) Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Alexion Pharmaceutical
• Grifols
• Avadel Pharmaceuticals
• Novartis
• Pfizer
• AbbVie
• F. Hoffmann-La Roche
• GlaxoSmithKline
• Bausch Health Companies
• Shire

Market segment by Type, the product can be split into

• Drug Treatment
• Rapid Immunotherapies
• Others

Market segment by Application, split into

• Hospitals and Clinics
• Diagnostic Centers
• Academic and Research Organizations

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Myasthenia Gravis (MG) Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Myasthenia Gravis (MG) Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Myasthenia Gravis (MG) Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Myasthenia Gravis (MG) Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Myasthenia Gravis (MG) Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Drug Treatment
  1.4.3 Rapid Immunotherapies
  1.4.4 Others
1.5 Market by Application
  1.5.1 Global Myasthenia Gravis (MG) Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals and Clinics
  1.5.3 Diagnostic Centers
  1.5.4 Academic and Research Organizations
1.6 Coronavirus Disease 2019 (Covid-19): Myasthenia Gravis (MG) Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Myasthenia Gravis (MG) Treatment Industry
    1.6.1.1 Myasthenia Gravis (MG) Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Myasthenia Gravis (MG) Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Myasthenia Gravis (MG) Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Myasthenia Gravis (MG) Treatment Market Perspective (2015-2026)
2.2 Myasthenia Gravis (MG) Treatment Growth Trends by Regions
  2.2.1 Myasthenia Gravis (MG) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Myasthenia Gravis (MG) Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Myasthenia Gravis (MG) Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Myasthenia Gravis (MG) Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Myasthenia Gravis (MG) Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Myasthenia Gravis (MG) Treatment Players by Market Size
  3.1.1 Global Top Myasthenia Gravis (MG) Treatment Players by Revenue (2015-2020)
  3.1.2 Global Myasthenia Gravis (MG) Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Myasthenia Gravis (MG) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Myasthenia Gravis (MG) Treatment Market Concentration Ratio
  3.2.1 Global Myasthenia Gravis (MG) Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Myasthenia Gravis (MG) Treatment Revenue in 2019
3.3 Myasthenia Gravis (MG) Treatment Key Players Head office and Area Served
3.4 Key Players Myasthenia Gravis (MG) Treatment Product Solution and Service
3.5 Date of Enter into Myasthenia Gravis (MG) Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Myasthenia Gravis (MG) Treatment Historic Market Size by Type (2015-2020)
4.2 Global Myasthenia Gravis (MG) Treatment Forecasted Market Size by Type (2021-2026)

5 MYASTHENIA GRAVIS (MG) TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020)
5.2 Global Myasthenia Gravis (MG) Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Myasthenia Gravis (MG) Treatment Market Size (2015-2020)
6.2 Myasthenia Gravis (MG) Treatment Key Players in North America (2019-2020)
6.3 North America Myasthenia Gravis (MG) Treatment Market Size by Type (2015-2020)
6.4 North America Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Myasthenia Gravis (MG) Treatment Market Size (2015-2020)
7.2 Myasthenia Gravis (MG) Treatment Key Players in Europe (2019-2020)
7.3 Europe Myasthenia Gravis (MG) Treatment Market Size by Type (2015-2020)
7.4 Europe Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Myasthenia Gravis (MG) Treatment Market Size (2015-2020)
8.2 Myasthenia Gravis (MG) Treatment Key Players in China (2019-2020)
8.3 China Myasthenia Gravis (MG) Treatment Market Size by Type (2015-2020)
8.4 China Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Myasthenia Gravis (MG) Treatment Market Size (2015-2020)
9.2 Myasthenia Gravis (MG) Treatment Key Players in Japan (2019-2020)
9.3 Japan Myasthenia Gravis (MG) Treatment Market Size by Type (2015-2020)
9.4 Japan Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Myasthenia Gravis (MG) Treatment Market Size (2015-2020)
10.2 Myasthenia Gravis (MG) Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Myasthenia Gravis (MG) Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Myasthenia Gravis (MG) Treatment Market Size (2015-2020)
11.2 Myasthenia Gravis (MG) Treatment Key Players in India (2019-2020)
11.3 India Myasthenia Gravis (MG) Treatment Market Size by Type (2015-2020)
11.4 India Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Myasthenia Gravis (MG) Treatment Market Size (2015-2020)
12.2 Myasthenia Gravis (MG) Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Myasthenia Gravis (MG) Treatment Market Size by Type (2015-2020)
12.4 Central & South America Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Alexion Pharmaceutical
  13.1.1 Alexion Pharmaceutical Company Details
  13.1.2 Alexion Pharmaceutical Business Overview and Its Total Revenue
  13.1.3 Alexion Pharmaceutical Myasthenia Gravis (MG) Treatment Introduction
  13.1.4 Alexion Pharmaceutical Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020))
  13.1.5 Alexion Pharmaceutical Recent Development
13.2 Grifols
  13.2.1 Grifols Company Details
  13.2.2 Grifols Business Overview and Its Total Revenue
  13.2.3 Grifols Myasthenia Gravis (MG) Treatment Introduction
  13.2.4 Grifols Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020)
  13.2.5 Grifols Recent Development
13.3 Avadel Pharmaceuticals
  13.3.1 Avadel Pharmaceuticals Company Details
  13.3.2 Avadel Pharmaceuticals Business Overview and Its Total Revenue
  13.3.3 Avadel Pharmaceuticals Myasthenia Gravis (MG) Treatment Introduction
  13.3.4 Avadel Pharmaceuticals Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020)
  13.3.5 Avadel Pharmaceuticals Recent Development
13.4 Novartis
  13.4.1 Novartis Company Details
  13.4.2 Novartis Business Overview and Its Total Revenue
  13.4.3 Novartis Myasthenia Gravis (MG) Treatment Introduction
  13.4.4 Novartis Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020)
  13.4.5 Novartis Recent Development
13.5 Pfizer
  13.5.1 Pfizer Company Details
  13.5.2 Pfizer Business Overview and Its Total Revenue
  13.5.3 Pfizer Myasthenia Gravis (MG) Treatment Introduction
  13.5.4 Pfizer Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020)
  13.5.5 Pfizer Recent Development
13.6 AbbVie
  13.6.1 AbbVie Company Details
  13.6.2 AbbVie Business Overview and Its Total Revenue
  13.6.3 AbbVie Myasthenia Gravis (MG) Treatment Introduction
  13.6.4 AbbVie Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020)
  13.6.5 AbbVie Recent Development
13.7 F. Hoffmann-La Roche
  13.7.1 F. Hoffmann-La Roche Company Details
  13.7.2 F. Hoffmann-La Roche Business Overview and Its Total Revenue
  13.7.3 F. Hoffmann-La Roche Myasthenia Gravis (MG) Treatment Introduction
  13.7.4 F. Hoffmann-La Roche Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020)
  13.7.5 F. Hoffmann-La Roche Recent Development
13.8 GlaxoSmithKline
  13.8.1 GlaxoSmithKline Company Details
  13.8.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.8.3 GlaxoSmithKline Myasthenia Gravis (MG) Treatment Introduction
  13.8.4 GlaxoSmithKline Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020)
  13.8.5 GlaxoSmithKline Recent Development
13.9 Bausch Health Companies
  13.9.1 Bausch Health Companies Company Details
  13.9.2 Bausch Health Companies Business Overview and Its Total Revenue
  13.9.3 Bausch Health Companies Myasthenia Gravis (MG) Treatment Introduction
  13.9.4 Bausch Health Companies Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020)
  13.9.5 Bausch Health Companies Recent Development
13.10 Shire
  13.10.1 Shire Company Details
  13.10.2 Shire Business Overview and Its Total Revenue
  13.10.3 Shire Myasthenia Gravis (MG) Treatment Introduction
  13.10.4 Shire Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020)
  13.10.5 Shire Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Myasthenia Gravis (MG) Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Myasthenia Gravis (MG) Treatment Revenue
Table 3. Ranking of Global Top Myasthenia Gravis (MG) Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Myasthenia Gravis (MG) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Drug Treatment
Table 6. Key Players of Rapid Immunotherapies
Table 7. Key Players of Others
Table 8. COVID-19 Impact Global Market: (Four Myasthenia Gravis (MG) Treatment Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Myasthenia Gravis (MG) Treatment Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Myasthenia Gravis (MG) Treatment Players to Combat Covid-19 Impact
Table 13. Global Myasthenia Gravis (MG) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Myasthenia Gravis (MG) Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Myasthenia Gravis (MG) Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Myasthenia Gravis (MG) Treatment Market Share by Regions (2015-2020)
Table 17. Global Myasthenia Gravis (MG) Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Myasthenia Gravis (MG) Treatment Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Myasthenia Gravis (MG) Treatment Market Growth Strategy
Table 23. Main Points Interviewed from Key Myasthenia Gravis (MG) Treatment Players
Table 24. Global Myasthenia Gravis (MG) Treatment Revenue by Players (2015-2020) (Million US$)
Table 25. Global Myasthenia Gravis (MG) Treatment Market Share by Players (2015-2020)
Table 26. Global Top Myasthenia Gravis (MG) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Myasthenia Gravis (MG) Treatment as of 2019)
Table 27. Global Myasthenia Gravis (MG) Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Myasthenia Gravis (MG) Treatment Product Solution and Service
Table 30. Date of Enter into Myasthenia Gravis (MG) Treatment Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Myasthenia Gravis (MG) Treatment Market Size by Type (2015-2020) (Million US$)
Table 33. Global Myasthenia Gravis (MG) Treatment Market Size Share by Type (2015-2020)
Table 34. Global Myasthenia Gravis (MG) Treatment Revenue Market Share by Type (2021-2026)
Table 35. Global Myasthenia Gravis (MG) Treatment Market Size Share by Application (2015-2020)
Table 36. Global Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. Global Myasthenia Gravis (MG) Treatment Market Size Share by Application (2021-2026)
Table 38. North America Key Players Myasthenia Gravis (MG) Treatment Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Myasthenia Gravis (MG) Treatment Market Share (2019-2020)
Table 40. North America Myasthenia Gravis (MG) Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. North America Myasthenia Gravis (MG) Treatment Market Share by Type (2015-2020)
Table 42. North America Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. North America Myasthenia Gravis (MG) Treatment Market Share by Application (2015-2020)
Table 44. Europe Key Players Myasthenia Gravis (MG) Treatment Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Myasthenia Gravis (MG) Treatment Market Share (2019-2020)
Table 46. Europe Myasthenia Gravis (MG) Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Myasthenia Gravis (MG) Treatment Market Share by Type (2015-2020)
Table 48. Europe Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Myasthenia Gravis (MG) Treatment Market Share by Application (2015-2020)
Table 50. China Key Players Myasthenia Gravis (MG) Treatment Revenue (2019-2020) (Million US$)
Table 51. China Key Players Myasthenia Gravis (MG) Treatment Market Share (2019-2020)
Table 52. China Myasthenia Gravis (MG) Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. China Myasthenia Gravis (MG) Treatment Market Share by Type (2015-2020)
Table 54. China Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. China Myasthenia Gravis (MG) Treatment Market Share by Application (2015-2020)
Table 56. Japan Key Players Myasthenia Gravis (MG) Treatment Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Myasthenia Gravis (MG) Treatment Market Share (2019-2020)
Table 58. Japan Myasthenia Gravis (MG) Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Myasthenia Gravis (MG) Treatment Market Share by Type (2015-2020)
Table 60. Japan Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Myasthenia Gravis (MG) Treatment Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Myasthenia Gravis (MG) Treatment Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Myasthenia Gravis (MG) Treatment Market Share (2019-2020)
Table 64. Southeast Asia Myasthenia Gravis (MG) Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Myasthenia Gravis (MG) Treatment Market Share by Type (2015-2020)
Table 66. Southeast Asia Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Myasthenia Gravis (MG) Treatment Market Share by Application (2015-2020)
Table 68. India Key Players Myasthenia Gravis (MG) Treatment Revenue (2019-2020) (Million US$)
Table 69. India Key Players Myasthenia Gravis (MG) Treatment Market Share (2019-2020)
Table 70. India Myasthenia Gravis (MG) Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. India Myasthenia Gravis (MG) Treatment Market Share by Type (2015-2020)
Table 72. India Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. India Myasthenia Gravis (MG) Treatment Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Myasthenia Gravis (MG) Treatment Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Myasthenia Gravis (MG) Treatment Market Share (2019-2020)
Table 76. Central & South America Myasthenia Gravis (MG) Treatment Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Myasthenia Gravis (MG) Treatment Market Share by Type (2015-2020)
Table 78. Central & South America Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Myasthenia Gravis (MG) Treatment Market Share by Application (2015-2020)
Table 80. Alexion Pharmaceutical Company Details
Table 81. Alexion Pharmaceutical Business Overview
Table 82. Alexion Pharmaceutical Product
Table 83. Alexion Pharmaceutical Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020) (Million US$)
Table 84. Alexion Pharmaceutical Recent Development
Table 85. Grifols Company Details
Table 86. Grifols Business Overview
Table 87. Grifols Product
Table 88. Grifols Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020) (Million US$)
Table 89. Grifols Recent Development
Table 90. Avadel Pharmaceuticals Company Details
Table 91. Avadel Pharmaceuticals Business Overview
Table 92. Avadel Pharmaceuticals Product
Table 93. Avadel Pharmaceuticals Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020) (Million US$)
Table 94. Avadel Pharmaceuticals Recent Development
Table 95. Novartis Company Details
Table 96. Novartis Business Overview
Table 97. Novartis Product
Table 98. Novartis Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020) (Million US$)
Table 99. Novartis Recent Development
Table 100. Pfizer Company Details
Table 101. Pfizer Business Overview
Table 102. Pfizer Product
Table 103. Pfizer Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020) (Million US$)
Table 104. Pfizer Recent Development
Table 105. AbbVie Company Details
Table 106. AbbVie Business Overview
Table 107. AbbVie Product
Table 108. AbbVie Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020) (Million US$)
Table 109. AbbVie Recent Development
Table 110. F. Hoffmann-La Roche Company Details
Table 111. F. Hoffmann-La Roche Business Overview
Table 112. F. Hoffmann-La Roche Product
Table 113. F. Hoffmann-La Roche Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020) (Million US$)
Table 114. F. Hoffmann-La Roche Recent Development
Table 115. GlaxoSmithKline Business Overview
Table 116. GlaxoSmithKline Product
Table 117. GlaxoSmithKline Company Details
Table 118. GlaxoSmithKline Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020) (Million US$)
Table 119. GlaxoSmithKline Recent Development
Table 120. Bausch Health Companies Company Details
Table 121. Bausch Health Companies Business Overview
Table 122. Bausch Health Companies Product
Table 123. Bausch Health Companies Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020) (Million US$)
Table 124. Bausch Health Companies Recent Development
Table 125. Shire Company Details
Table 126. Shire Business Overview
Table 127. Shire Product
Table 128. Shire Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020) (Million US$)
Table 129. Shire Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Myasthenia Gravis (MG) Treatment Market Share by Type: 2020 VS 2026
Figure 2. Drug Treatment Features
Figure 3. Rapid Immunotherapies Features
Figure 4. Others Features
Figure 5. Global Myasthenia Gravis (MG) Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals and Clinics Case Studies
Figure 7. Diagnostic Centers Case Studies
Figure 8. Academic and Research Organizations Case Studies
Figure 9. Myasthenia Gravis (MG) Treatment Report Years Considered
Figure 10. Global Myasthenia Gravis (MG) Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Myasthenia Gravis (MG) Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Myasthenia Gravis (MG) Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Myasthenia Gravis (MG) Treatment Market Share by Players in 2019
Figure 15. Global Top Myasthenia Gravis (MG) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Myasthenia Gravis (MG) Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Myasthenia Gravis (MG) Treatment Revenue in 2019
Figure 17. North America Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Alexion Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Alexion Pharmaceutical Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2015-2020)
Figure 26. Grifols Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Grifols Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2015-2020)
Figure 28. Avadel Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Avadel Pharmaceuticals Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2015-2020)
Figure 30. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Novartis Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2015-2020)
Figure 32. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Pfizer Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2015-2020)
Figure 34. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. AbbVie Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2015-2020)
Figure 36. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. F. Hoffmann-La Roche Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2015-2020)
Figure 38. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. GlaxoSmithKline Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2015-2020)
Figure 40. Bausch Health Companies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Bausch Health Companies Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2015-2020)
Figure 42. Shire Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Shire Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed